Major depressive disorder (MDD) is considered a major cause of disability throughout the world (Belmaker & Agam, 2008). Clinically, MDD is a heterogeneous disorder that is characterized by persistent mood instability, anhedonia, insomnia, loss of energy and cognitive dysfunction (MacQueen & Frodl, 2011). In addition to these clinical symptoms, structural magnetic resonance imaging (MRI) scans of patients suffering from depression show reduced gray matter volume in areas of the brain including the hippocampus, insula, thalamus and nucleus accumbens (Ancelin et al., 2019;Joshi et al., 2015). Moreover, studies show that affected patients have decreased left and right hippocampal volume as compared to controls and that the hippocampal CA1 region is particularly affected (Cole, Costafreda, McGuffin, & Fu, 2011;Cole et al., 2010).Although clinical symptoms and structural changes in MDD patients have been relatively well investigated, less is known about the molecular mechanisms that underlie these changes. Some studies suggest that the onset of depression can be triggered by exposure to traumatic life events or stress-